Opening Bell Analysts Research Calls for Tuesday, January 31

This report was sent to Briefing.com subscribers earlier today. 

Research calls posted earlier this morning are available here. 

Upgrades:

> BAE Systems (BAESY) upgraded to Buy from Neutral at UBS

> Banco de Sabadell (BNDSF) upgraded to Buy from Neutral at UBS

> FleetCor (FLT) upgraded to Buy from Neutral at BofA Securities; tgt raised to $240

> Silvercorp Metals (SVM) upgraded to Outperform from Mkt Perform at Raymond James

> Williams Cos (WMB) upgraded to Overweight from Hold at US Capital Advisors; tgt $36

Downgrades:

> Airbus (EADSY) downgraded to Sell from Buy at UBS

> Crestwood Equity Partners (CEQP) downgraded to Hold from Buy at US Capital Advisors; tgt $29

> DCP Midstream (DCP) downgraded to Hold from Buy at US Capital Advisors; tgt $42

> Edwards Lifesciences (EW) downgraded to Underperform from Outperform at Bernstein; tgt lowered to $66

> Enerflex (EFXT) downgraded to Sector Perform from Outperform at National Bank Financial

> Finmeccanica SpA (FINMY) downgraded to Neutral from Buy at UBS

> Hapag-Lloyd Aktiengesellschaft (HPGLY) downgraded to Reduce from Hold at Kepler

> HomeStreet (HMST) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt lowered to $29

> Legal & General Group (LGGNY) downgraded to Hold from Buy at Berenberg

> Nokia (NOK) downgraded to Neutral from Buy at UBS

> Paramount Global (PARA) downgraded to Underperform from Neutral at Macquarie; tgt $15

> Ponce Financial Group (PDLB) downgraded to Sell from Buy at Compass Point; tgt lowered to $9

> Sierra Bancorp (BSRR) downgraded to Market Perform from Outperform at Hovde Group; tgt $24

> Thales (THLEF) downgraded to Neutral from Buy at UBS

> Truist (TFC) downgraded to Equal-Weight from Overweight at Stephens; tgt $53

> World Wrestling (WWE) downgraded to Peer Perform from Outperform at Wolfe Research

Others:

> AmerisourceBergen (ABC) resumed with an Outperform at Evercore ISI; tgt $185

> ARS Pharmaceuticals (SPRY) initiated with an Outperform at Wedbush; tgt $10

> Compass Therapeutics (CMPX) initiated with a Buy at Jefferies; tgt $8

> Cutera (CUTR) initiated with a Mkt Perform at William Blair

> Fox Corporation (FOXA) resumed with an Equal-Weight at Morgan Stanley; tgt $37

> IBM (IBM) removed from Tactical Outperform list at Evercore ISI

> Meta Platforms (META) initiated with a Buy at Lightshed Partners; tgt $200

> Pacira BioSciences (PCRX) assumed with an Outperform at Wedbush; tgt lowered to $60

> Rain Oncology (RAIN) resumed with a Buy at ROTH Capital; tgt $21

> Syndax Pharmaceuticals (SNDX) initiated with a Buy at Stifel; tgt $37

> Xometry (XMTR) initiated with a Buy at Craig Hallum; tgt $48

Sponsored: Tips for Investing

A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.

Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.

Source: Read Full Article